CDKL2 抗体 (AA 394-493)
Quick Overview for CDKL2 抗体 (AA 394-493) (ABIN563901)
抗原
See all CDKL2 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
- 
    - 
                                            抗原表位
- AA 394-493
- 
                                            原理
- Mouse monoclonal antibody raised against a partial recombinant CDKL2.
- 
                                            序列
- LKDCSNVSVD HTRNPSVAIP PLTHNLSAVA PSINSGMGTE TIPIQGYRVD EKTKKCSIPF VKPNRHSPSG IYNINVTTLV SGPPLSDDSG ADLPQMEHQH
- 
                                            交叉反应
- 人
- 
                                            产品特性
- Antibody Reactive Against Recombinant Protein.
- 
                                            免疫原
- CDKL2 (NP_003939, 394 a.a. ~ 493 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
- 
                                            亚型
- IgG1
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- Optimal working dilution should be determined by the investigator.
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            缓冲液
- In 1x PBS, pH 7.4
- 
                                            注意事项
- Aliquot to avoid repeated freezing and thawing.
- 
                                            储存条件
- -20 °C
- 
                                            储存方法
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
 
- 
                                            
- 
    - CDKL2 (Cyclin Dependent Kinase Like 2 (CDKL2))
- 
                                            别名
- CDKL2
- 
                                            背景
- 
                        Full Gene Name: cyclin-dependent kinase-like 2 (CDC2-related kinase)
 Synonyms: KKIAMRE,P56
- 
                                            基因ID
- 8999
- 
                                            NCBI登录号
- NM_003948
 抗原
- 
                    
 
                                     
                                     
                                    